Skip to main content
Premium Trial:

Request an Annual Quote

More Genomes Sequenced by 100K Genome Project

NEW YORK (GenomeWeb News) – The 100K Genome Project announced on Monday that 20 newly completed genome sequences of food-borne, disease-causing microorganisms has been added to its public database at the National Center for Biotechnology Information.

In total, 30 genomic sequences have been completed by the project, whose goal is to sequence the genomes of 100,000 bacterial and viral genomes as part of an effort to accelerate the diagnosis and treatment of food-borne diseases and limit the duration and spread of such outbreaks, 100K Genome Project said.

A complete list of the genomes which have been sequenced as part of the project is available here.

The new sequences include several isolates of Salmonella, Listeria, Campylobacter, and Vibrio. Also included are the full characterizations of their epigenomes.

"These finished genome sequences represent the highest quality standard, with each strain closed in a single bacterial chromosome and their associated mobile DNA," Bart Weimer, director of the 100K Genome Project, said in a statement. "They also contain complete associated phage or plasmid elements, which are critical for understanding pathogenicity, drug resistance, and other biologically important trains that are linked to survival."

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.